908 FETAL LUNG DEVELOPMENT AFTER AMNIOCENTESIS

Abstract

The effects of amniocentesis (Ax) on the growth and development of fetal rat lung were studied in littermate fetuses subjected to minimum (Ax-Min; 0.1 ml) and maximum volume (Ax-Max; 0.5 ml+) amniocentesis at 17 days gestation. Non-operated littermates served as controls. Lungs of 12-14 fetuses/group were analyzed at term (22 days) for weight, composition (DNA, glycogen, lipid, phospholipid, phosphatidyl-choline) and histology (light and EM). Only Ax-Max reduced the weight of the lung (p>.1). DNA content was not influenced by Ax. Both Ax-Max (p>.02) and Ax-Min (p>.1) reduced lung glycogen. Ax did not alter the quantity of lung lipid at birth. The phospholipid fraction/lung was reduced (p>.05) after Ax-Max but not Ax-Min. The lungs of Ax-Max fetuses showed reduced alveolar space size and type II pneumocytes with few lamellar bodies and little glycogen. Histologic changes were not observed after Ax-Min. These studies indicated that large volume Ax reduces lung size by obliterating the fetal lung space rather than inhibiting lung cell proliferation. Ax-Max also reduces the phospholipid and surfactant pool size. Ax-min results in few detectable changes in lung growth or development. These studies explain certain aspects of the pulmonary dysfunction of infants with prolonged oligohydramnios.

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account

Continue with Google

Continue with ORCiD